The Percept RC, a rechargeable neurostimulator, is the latest device in the company’s Percept device family, which includes another neurostimulator, technology that receives and records brain signals and directional leads, according to a Jan. 8 Medtronic news release. The system treats patients with movement disorders such as Parkinson’s disease and epilepsy.
Medtronic also recently earned FDA approval for its irregular heartbeat device and put funding into the expansion of its GI Genius module.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
